Glenmark Pharma gets tentative USFDA nod for Clobetasol Propionate foam to treat Skin ailments Medical Dialogues Bureau26 Nov 2018 12:21 PM ISTNew Delhi: Glenmark Pharmaceuticals Monday said it has received a tentative nod from the US health regulator for Clobetasol Propionate foam, used to...
U.S. benefits manager baulks after Novartis values gene therapy at $4-5 million Medical Dialogues Bureau26 Nov 2018 9:59 AM ISTZURICH: Just weeks after Novartis floated the idea that $4-5 million was fair value for its new gene therapy against a deadly neuromuscular disease, a...
Pricing might be tested with costly eye therapy: Novartis Medical Dialogues Bureau26 Nov 2018 9:38 AM ISTZURICH: Novartis price-setting muscle is about to be tested after it won European Union approval for a blindness-fighting gene therapy whose $850,000...
Lupin launches ANYA- India's first chatbot for patients Medical Dialogues Bureau25 Nov 2018 12:57 PM ISTAhmedabad: Pharma major Lupin announced the launch of a chatbot named ‘ANYA’ specially designed to provide medically verified information for...
US appeals court declines J&J bid to stop sales of generic version of Blockbuster cancer drug Zytiga Medical Dialogues Bureau25 Nov 2018 9:24 AM ISTNew Delhi: A U.S. appeals court declined a request by Johnson & Johnson for a temporary restraining order blocking sales of generic versions of...
Indoco Remedies gets two minor observations from USFDA for Goa plants Medical Dialogues Bureau25 Nov 2018 9:07 AM ISTMumbai: Drug firm Indoco Remedies on Thursday said it has received two minor observations from the US health regulator for its Goa-based two plants....
NPPA withdraws the ceiling price of Vitamin A Oral liquid Medical Dialogues Bureau24 Nov 2018 3:09 PM ISTNew Delhi: Through a recent notice, National Pharmaceutical Pricing Authority(NPPA) has decided to withdraw the ceiling price of Vitamin A Oral liquid...
Novartis Luxturna Gene Therapy for restoring Eyesight in Rare retinal diseases gets European Approval Medical Dialogues Bureau24 Nov 2018 1:24 PM ISTLuxturna is first gene therapy for a genetic disease approved in both the U.S. and EU. Luxturna is first and only gene therapy approved in EU for...
Roots and shoots: China seeks new markets for ancient medicines Medical Dialogues Bureau24 Nov 2018 9:24 AM ISTNew Delhi: Shanghai, Nov 21, 2018 -A crowd gathers at a Shanghai hospital, queuing for remedies made with plant mixtures and animal parts including...
AstraZeneca sells infant drug rights to Sobi for $1.5 bln upfront Medical Dialogues Bureau24 Nov 2018 9:00 AM ISTLONDON: AstraZeneca took another step to refocus its portfolio on priority projects on Tuesday by selling U.S. rights to a treatment for a serious...
Glenmark gets USFDA nod for pneumonia treatment drug Medical Dialogues Bureau23 Nov 2018 12:15 PM ISTNew Delhi: Glenmark Pharmaceuticals Thursday said it has received final approval from the US health regulator for Atovaquone, used for prevention and...
Zydus Cadila gets USFDA nod for generic cholesterol drug Garima23 Nov 2018 12:15 PM ISTNew Delhi: Drug maker Zydus Cadila Thursday said it has received approval from the US health regulator to market cholesterol-lowering drug...
